Low-molecular weight human interleukin-1β antagonist discovered

Researchers described the detection of a human interleukin-1β antagonist with low molecular weight that disrupts interactions with the interleukin-1 receptor type I receptor.

Solving astronauts’ health challenges in deep space could have payoffs on Earth

Space is famously known as the final frontier for human exploration. It may also be the final frontier for human medicine. That’s what Dorit Donoviel,

February 16, 2024

Managing temperature-sensitive injectable drugs in fill finish operations – Pharmaceutical Technology

Temperature sensitivity is a primary concern for many parenteral drug products. Certain medications require cold storage, freezing, or lyophilization to manage this sensitivity. However, a

September 25, 2024

High ADHD Medication Doses Tied to Psychosis; Rapid Tests for Malaria

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

September 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.